Clinical Trials Directory

Trials / Unknown

UnknownNCT02465996

Gastric Barrier Dysfunction of Functional Dyspepsia and Therapeutic Response to Puyuanhewei Detected by Endomicroscopy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Shandong University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Functional dyspepsia might have impaired gastric mucosal dysfunction and Puyuanhewei may be helpful to improve the symptoms of FD.

Detailed description

This study aimed to investigate the gastric mucosal dysfunction in functional dyspepsia (FD) and verify the efficacy of Puyuanhewei for treating FD and assess the relationship between gastric microalterations and therapeutic response by endomicroscopy.

Conditions

Interventions

TypeNameDescription
DEVICEpCLE examinationAll FD patients received pCLE examination.
DRUGPuyuanheweiFD patients willing to receive Puyuanhewei were given 4 pills three times a day regardless of PDS or EPS for 4 weeks after pCLE examination.

Timeline

Start date
2014-07-01
Primary completion
2015-06-01
Completion
2015-06-01
First posted
2015-06-09
Last updated
2015-06-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02465996. Inclusion in this directory is not an endorsement.

Gastric Barrier Dysfunction of Functional Dyspepsia and Therapeutic Response to Puyuanhewei Detected by Endomicroscopy (NCT02465996) · Clinical Trials Directory